Research programme: respiratory disorders therapeutics - Exonate
Alternative Names: respiratory disorders therapeutics; respiratory disorders therapeutics ExonateLatest Information Update: 30 Jun 2023
At a glance
- Originator Exonate
- Class Antifibrotics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Idiopathic pulmonary fibrosis
Most Recent Events
- 21 Apr 2023 Early research in Idiopathic pulmonary fibrosis in United Kingdom (unspecified route) (Exonate pipeline, April 2023)